Irati Zubizarreta

Barcelona, CT, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 25 publications

Predicting disease severity in multiple sclerosis using multimodal data and machine learning.

Predicting disease severity in multiple sclerosis using multimodal data and machine learning.

Journal: Journal of neurology

Published: June 24, 2023

Oligoclonal IgM bands in the cerebrospinal fluid of patients with relapsing MS to inform long-term MS disability.

Oligoclonal IgM bands in the cerebrospinal fluid of patients with relapsing MS to inform long-term MS disability.

Journal: Multiple sclerosis (Houndmills, Basingstoke, England)

Published: January 12, 2021

Recommendations for the coordination of Neurology and Neuroradiology Departments in the management of patients with multiple sclerosis.

Recommendations for the coordination of Neurology and Neuroradiology Departments in the management of patients with multiple sclerosis.

Journal: Neurologia

Published: December 23, 2020

Retinal and brain damage during multiple sclerosis course: inflammatory activity is a key factor in the first 5 years.

Retinal and brain damage during multiple sclerosis course: inflammatory activity is a key factor in the first 5 years.

Journal: Scientific reports

Published: November 02, 2019

Using Acute Optic Neuritis Trials to Assess Neuroprotective and Remyelinating Therapies in Multiple Sclerosis.

Using Acute Optic Neuritis Trials to Assess Neuroprotective and Remyelinating Therapies in Multiple Sclerosis.

Journal: JAMA neurology

Published: October 01, 2019

Rebound of multiple sclerosis activity after fingolimod withdrawal due to planning pregnancy: Analysis of predisposing factors.

Rebound of multiple sclerosis activity after fingolimod withdrawal due to planning pregnancy: Analysis of predisposing factors.

Journal: Multiple sclerosis and related disorders

Published: July 15, 2019

MAPK pathway and B cells overactivation in multiple sclerosis revealed by phosphoproteomics and genomic analysis.

MAPK pathway and B cells overactivation in multiple sclerosis revealed by phosphoproteomics and genomic analysis.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: April 21, 2019

Immune tolerance in multiple sclerosis and neuromyelitis optica with peptide-loaded tolerogenic dendritic cells in a phase 1b trial.

Immune tolerance in multiple sclerosis and neuromyelitis optica with peptide-loaded tolerogenic dendritic cells in a phase 1b trial.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: April 10, 2019

Axonal and Myelin Neuroprotection by the Peptoid BN201 in Brain Inflammation.

Axonal and Myelin Neuroprotection by the Peptoid BN201 in Brain Inflammation.

Journal: Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics

Published: March 01, 2019

Spanish validation of the telephone assessed Expanded Disability Status Scale and Patient Determined Disease Steps in people with multiple sclerosis.

Spanish validation of the telephone assessed Expanded Disability Status Scale and Patient Determined Disease Steps in people with multiple sclerosis.

Journal: Multiple sclerosis and related disorders

Published: July 20, 2018

Assessing Biological and Methodological Aspects of Brain Volume Loss in Multiple Sclerosis.

Assessing Biological and Methodological Aspects of Brain Volume Loss in Multiple Sclerosis.

Journal: JAMA neurology

Published: July 05, 2018

Magnetic resonance markers of tissue damage related to connectivity disruption in multiple sclerosis.

Magnetic resonance markers of tissue damage related to connectivity disruption in multiple sclerosis.

Journal: NeuroImage. Clinical

Published: December 05, 2017

Showing 1-12 of 25

Last Updated: 09/26/2026